Výsledky vyhledávání - "Unresectable Esophageal Carcinoma"

Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients

Autor: Michel Rives, Amélie Lusque, C. Dalmasso, N. Carrère, Elizabeth Cohen-Jonathan Moyal, F. Izar, A. Modesto, Laure Vieillevigne, R. Guimbaud

Publikováno v: Cancer/Radiothérapie. 24:88-92

Purpose The optimal dose in esophageal cancer patients treated with definitive chemoradiation (CRT) remains debated. We herein report on the dosimetric results, treatment-related toxicities and long-term outcomes of escalated dose up to 60 Gy deliver

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567674900c0a85572545f00c258f60bc
https://doi.org/10.1016/j.canrad.2020.01.006

Zobrazit plný text záznamu

Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE)

Autor: Keisuke Hori, Hiroyuki Daiko, Takeshi Sakamoto, Junki Mizusawa, Ken Kato, Mitsumi Terada, Takashi Ogata, Tomohiro Kadota, Yuko Kitagawa, Katsuyuki Sakanaka, Hiroki Hara, Hirofumi Ogawa

Publikováno v: Japanese Journal of Clinical Oncology. 49:1055-1060

A randomized phase III trial commenced in Japan in February 2018. Definitive chemoradiotherapy (CRT) with cisplatin plus 5-fluorouracil is the current standard treatment for locally advanced unresectable esophageal carcinoma. The purpose of this stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f71acfa885f1ae999a718f8ff57799cc
https://doi.org/10.1093/jjco/hyz112

Zobrazit plný text záznamu

OUTCOMES OF TREATMENT OF UNRESECTABLE ESOPHAGEAL CARCINOMA TREATED WITH CHEMORADIOTHERAPY AND ORAL METRONOMIC CHEMOTHERAPY: AN EXPERIENCE FROM A RURAL CANCER CENTER

Autor: Ashish Desai, Joydeep Ghosh, A Kulkarni, Ashish Pokharkar, Nandini Sharma, M V Chandrakanth, S D Banavali, Amit Mandhare

Publikováno v: Eastern Journal Of Medical Sciences. 1:50-53

Introduction: Esophageal carcinoma is the eight most common cancer in the world. The management of locally advancedcarcinoma esophagus is mainly palliative with chemoradiotherapy. The outcome data of such a modality along with oralmetronomic chemothe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e8071e5678e39db00d6b29ea06eadab8
https://doi.org/10.32677/ejms.2016.v01.i02.003

Zobrazit plný text záznamu

Problematic esophageal stricture: an emerging indication for self-expandable silicone stents

Autor: Massimo Raimondo, Surakit Pungpapong, Michael B. Wallace, Timothy A. Woodward

Publikováno v: Gastrointestinal Endoscopy. 60:842-845

Self-expandable metal stents (SEMS) are routinely used to palliate patients with dysphagia caused by unresectable esophageal carcinoma, as well as patients with this malignancy who are poor candidatesforsurgery.However,placementofSEMS in proximal eso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a72852a099922f4f8b0effaccfadf46
https://doi.org/10.1016/s0016-5107(04)02035-8

Zobrazit plný text záznamu

Endoscopic Injection of Mitomycin Adsorbed on Carbon Particles for Advanced Esophageal Cancer: a Pilot Study

Autor: J. Wirth, H. Ernst, Stefan Schreiber, A. A. M. Taha, J. Weber-Eibl, H. Lochs, M.-A. E. J. Ortner

Publikováno v: Endoscopy. 36:421-425

BACKGROUND AND STUDY AIMS Patients with advanced, unresectable esophageal carcinoma have an extremely poor prognosis, with dysphagia being the major problem. The aim of this prospective pilot study was to evaluate the efficacy of local injections of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56fdc1deab0e9616f3c84076af04e682
https://doi.org/10.1055/s-2004-814327

Zobrazit plný text záznamu

Palliation of malignant dysphagia by laser therapy

Autor: A. P. Savage, H. Barr, R. J. Baigrie, R. A. Cobb, M. G. W. Kettlewell

Publikováno v: Diseases of the Esophagus. 10:243-246

The outcome of 211 patients undergoing laser therapy as palliation for inoperable carcinoma of the esophagus is presented. The median age was 73 (range 44-97). The histology was adenocarcinoma for 127 patients and squamous-cell carcinoma for 84 patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16461a3cc3cc3e7ebfd44443e6217aa6
https://doi.org/10.1093/dote/10.4.243

Zobrazit plný text záznamu

Palliative therapy for patients with unresectable esophageal carcinoma

Autor: Richard K. Freeman, Raja J. Mahidhara, Anthony J. Ascioti

Publikováno v: The Surgical clinics of North America. 92(5)

Most patients diagnosed with carcinoma of the esophagus do not undergo therapy with curative intent. The focus of treatment for these patients is to maximize their progression-free survival and palliate the most common sequelae of their disease: dysp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09a59910f7902b4d3a8b38042ea061f3
https://pubmed.ncbi.nlm.nih.gov/23026285

Zobrazit plný text záznamu

Salvage endoscopic submucosal dissection for recurrent esophageal squamous-cell carcinoma after definitive chemoradiotherapy

Autor: Naoki Ishii, Koyu Suzuki, Yoshiyuki Fujita

Publikováno v: Clinical journal of gastroenterology. 4(2)

Although concurrent definitive chemoradiotherapy (CRT) is considered a standard treatment for unresectable esophageal carcinoma, CRT is associated with local failure (40–50%), and further interventions are needed in these cases. However, morbidity

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed12ca7b8e1653a0c755b9fba9d55a36
https://pubmed.ncbi.nlm.nih.gov/26190711

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání